BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tieu T, Irani S, Bremert KL, Ryan NK, Wojnilowicz M, Helm M, Thissen H, Voelcker NH, Butler LM, Cifuentes-Rius A. Patient-Derived Prostate Cancer Explants: A Clinically Relevant Model to Assess siRNA-Based Nanomedicines. Adv Healthc Mater 2021;10:e2001594. [PMID: 33274851 DOI: 10.1002/adhm.202001594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang F, Tie Y, Hong WQ, He X, Min L, Zhou Y, Luo Y, Chen SY, Yang JY, Shi HH, Wei XW, Tu CQ. Patient-Derived Tumor Xenografts Plus Ex Vivo Models Enable Drug Validation for Tenosynovial Giant Cell Tumors. Ann Surg Oncol 2021. [PMID: 33748895 DOI: 10.1245/s10434-021-09836-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Perez LM, Nonn L. Harnessing the Utility of Ex Vivo Patient Prostate Tissue Slice Cultures. Front Oncol 2022;12:864723. [PMID: 35433436 DOI: 10.3389/fonc.2022.864723] [Reference Citation Analysis]
3 Chen Y, Alba M, Tieu T, Tong Z, Minhas RS, Rudd D, Voelcker NH, Cifuentes-rius A, Elnathan R. Engineering Micro–Nanomaterials for Biomedical Translation. Adv NanoBio Res 2021;1:2100002. [DOI: 10.1002/anbr.202100002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ashrafizadeh M, Paskeh MDA, Mirzaei S, Gholami MH, Zarrabi A, Hashemi F, Hushmandi K, Hashemi M, Nabavi N, Crea F, Ren J, Klionsky DJ, Kumar AP, Wang Y. Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. J Exp Clin Cancer Res 2022;41:105. [PMID: 35317831 DOI: 10.1186/s13046-022-02293-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Xue Y, Bai H, Peng B, Tieu T, Jiang J, Hao S, Li P, Richardson M, Baell J, Thissen H, Cifuentes A, Li L, Voelcker NH. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy. Adv Healthc Mater 2022;:e2200076. [PMID: 35306736 DOI: 10.1002/adhm.202200076] [Reference Citation Analysis]